THE TRUTH ABOUT: 9 - The Untold Story

Here's What to Expect From Merck & Co.'s Next Earnings Report

Merck & Co. is projected to report its third-quarter earnings result at the end of this month, and analysts expect a double-digit profit dip.

Barchart · Oct 17, 2024

Pharma company funding for patient advocacy groups needs to be transparent

Patient groups should be playing a central role in Canada’s health-care system, advocating for their members by promoting the visibility of their conditions, pushing for more rapid and accurate diagnoses and lobbying for the introduction and funding of new treatments and drugs that may help relieve their members’ symptoms and…

The Conversation · Oct 2, 2024

Ozempic, Wegovy, Rybelsus: Are we losing sight of overall health? Here’s what the science says

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analogue class, better known under the trade names Ozempic and Wegovy, is remarkable, but it’s not totally unprecedented in the history of pharmaceutical blockbusters.

The Conversation · Sep 12, 2024

Merck & Co. Stock: Analyst Estimates & Ratings

Despite Merck & Co.’s relative underperformance over the past year, Wall Street analysts remain bullish about the stock’s prospects.

Barchart · Aug 7, 2024

Vaccines tell a success story that Robert F. Kennedy Jr. and Trump forget – here are some key reminders

Vaccinations have provided significant protection for the public against infectious diseases. However, there was a modest decrease in support in 2023 nationwide for vaccine requirements for children to attend public schools.

The Conversation · Jul 26, 2024

Wall Street Billionaire Investors Dumped Nvidia Shares in Q1, Bought These Three Stocks Instead

Nvidia continues to innovate AI GPUs and maintains a strong balance sheet, but hedge fund managers see several headwinds for the company in the coming months.

International Business Times UK · Jul 17, 2024

Akira Endo obituary

Japanese biochemist whose work on fungal extracts led to the creation of the first statin

The Guardian - UK · Jul 5, 2024

3 Dow Dividend Stocks Beating the Market This Year

While all eyes are still on standout AI tech stocks, these three dividend-paying Dow stocks are beating the broader market this year.

Barchart · Jun 18, 2024

Is Merck & Company Stock Outperforming the Dow

Merck & Company has significantly outperformed the Dow Jones recently, and Wall Street analysts expect further gains for the stock.

Barchart · Jun 7, 2024

Do Wall Street Analysts Like Merck & Company Stock?

As Merck outperforms the broader market this year, Wall Street analysts remain optimistic about the stock's prospects.

Barchart · May 23, 2024